Highly Purified Menotrophin (HMG) is a human-derived gonadotropin preparation containing both Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) activities. Widely used in reproductive medicine, HMG plays a central role in stimulating ovarian development, ovulation induction, and controlled ovarian hyper-stimulation (COH). As an Active Pharmaceutical Ingredient (API) , Highly Purified Menotrophin is supplied in a robust, stable, and quality-controlled form suited for formulation, clinical development, and commercial manufacturing.

This HMG API is designed for pharmaceutical developers, OEM manufacturers, reproductive-health brands, and distributors seeking a reliable, traceable, and high-purity gonadotropin source for fertility-related injectable products.

Product Overview

Highly Purified Menotrophin is obtained from post-menopausal human urine or a purified equivalent source, then processed to deliver consistent FSH/LH bioactivity . The product is offered as a lyophilized (freeze-dried) powder to ensure stability, long shelf life, and ease of storage.

HMG's dual gonadotropic activity makes it a versatile backbone ingredient for modern fertility protocols, supporting both female and male reproductive therapies across human and veterinary applications.

Specifications & Quality Profile

Applications & Use Cases

Conclusion

Highly Purified Menotrophin (HMG) is an essential gonadotropin API for the development of modern fertility treatments across human and veterinary applications.